May 6, 2026 07:00AM
May 6, 2026 07:00AM
Mar 30, 2026 07:31AM
Mar 30, 2026 07:30AM
Feb 9, 2026 07:30AM
Jan 20, 2026 06:41AM
Jan 6, 2026 07:30AM Anavex receives FDA feedback on Alzheimer's disease drug program
Jan 6, 2026 07:30AM
Nov 14, 2025 07:31AM
Nov 14, 2025 07:30AM
Nov 14, 2025 07:30AM
Mar 31, 2025 06:43AM
Jul 29, 2024 07:15AM
Jul 28, 2024 05:00PM Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference
Jul 28, 2024 05:00PM
Jul 22, 2024 07:01AM
May 22, 2024 07:37AM
May 22, 2024 07:30AM
May 9, 2024 07:30AM
Apr 29, 2024 07:15AM
Apr 22, 2024 01:45AM ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Anavex Life Sciences Corporation Investors of Upcoming Deadline
Apr 20, 2024 09:00PM
Apr 16, 2024 09:00PM
Apr 15, 2024 11:15AM
Apr 12, 2024 09:00PM
Apr 1, 2024 11:30AM
Mar 25, 2024 12:30PM
Mar 18, 2024 12:30PM ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against An
Mar 18, 2024 07:30AM
Mar 14, 2024 12:30PM
Feb 7, 2024 07:30AM
Jan 16, 2024 07:31AM
Jan 16, 2024 07:30AM
Jan 2, 2024 08:01AM
Jan 2, 2024 08:00AM Anavex Life Sciences Provides an Update on Rett Syndrome Program
Nov 6, 2023 08:00AM
Jun 28, 2023 07:30AM
Jun 28, 2023 07:30AM
Jun 12, 2023 07:30AM
Jun 6, 2023 07:30AM
May 9, 2023 07:30AM
Mar 9, 2023 07:00AM Anavex Life Sciences Appoints Former FDA Lead Neurology Statistician as Vice President Head of Biostatistics
Feb 2, 2023 07:00AM
Nov 28, 2022 07:00AM
Nov 7, 2022 07:04AM
Nov 7, 2022 07:00AM
Aug 9, 2022 07:00AM
Aug 2, 2022 07:04AM
Aug 2, 2022 07:00AM Anavex Announces Long-lasting Effect of ANAVEX®3-71 Preventing Cognitive Decline in a Transgenic Rat Model of Alzheimer’s Disease at AAIC 2022
May 10, 2022 07:00AM

322,335 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All